Advertisement

Topics

BioGenes - Gesellschaft für Biopolymere mbH Company Profile

21:19 EDT 18th June 2018 | BioPortfolio

BioGenes is a world-wide acting full-service supplier of protein analysis services, customised polyclonal and monoclonal antibodies as well as immunoassays with strong commitment to quality and service.

BioGenes supports customers with a whole range of GMP-compliant analytical services starting from feasibility assessments to complete immunoassay development, validation, manufacturing, and implementation. BioGenes’ repertoire comprises the design of sandwich and competitive assays for the qualitative and quantitative determination of antigens or antibodies, and the development, validation and production of generic or process-specific Host Cell Protein ELISAs for quality control.

BioGenes develops monoclonal antibodies against all kinds of antigens (peptides, soluble proteins, membrane proteins, phosphorylated antigens, small organic molecules like haptens, oligo- and polysaccharides as well as highly toxic substances) including monoclonal antibodies that distinguish modified proteins and peptides from non-modified (e.g. phosphorylation, methylation etc.) as well as anti-idiotypic antibodies. For universities, institutes and industrial research BioGenes offers affordable routine polyclonal and monoclonal antibody development.

Successful long-term alliances with biotech and pharmaceutical companies prove that BioGenes is the partner of choice in the fields of protein analysis. BioGenes is certified to meet the international the international requirements and regularities of quality assurance and animal welfare.

Location

Köpenicker Straße 325
Berlin
D-12555
Germany

Contact

Phone: 49 (0)30 65762396
Fax: 49 (0)30 65762397
Email: kathrin.guenther@biogenes.de


News Articles [43 Associated News Articles listed on BioPortfolio]

Ears for Icarus

(Max-Planck-Gesellschaft) A Russian rocket delivers antenna for an animal tracking system to the International Space Station.

Loving the sweet enemy

(Max-Planck-Gesellschaft) Foods rich in fats and carbohydrates stimulate the reward system in the brain particularly strongly.

Pulmonary fibrosis caused by single transcription factor

(Max-Planck-Gesellschaft) Reduced FoxO3 activity reprograms connective tissue cells, triggering the disease.

Decoding the structure of huntingtin

(Max-Planck-Gesellschaft) Determining the three dimensional structure of the protein could help to develop new treatments of Huntington's disease.

One step closer to reality

(Max-Planck-Gesellschaft) The software 'PyFRAP' is an accurate and reliable tool for the analysis of molecular movement, employing numerical simulations rather than simplified assumptions.

Decoding the Axolotl genome

(Max-Planck-Gesellschaft) The sequencing of the largest genome to date lays the foundation for novel insights into tissue regeneration.

Scientists discover how protein molecules regulate formation of myelin sheaths

According to the Deutsche Multiple Sklerose Gesellschaft, around 200,000 people in Germany suffer from multiple sclerosis- a serious neurological condition that has no known cure.

BB-Biotech-Beteiligung Incyte vor Mega-Comeback? Das ist entscheidend!

Es ist in den letzten Monaten ruhig um die Aktie von Incyte geworden. Seit dem Rekordhoch bei 132,14 Dollar vom März 2017 hat die Biotech-Gesellschaft in der Spitze 47 Prozent an Wert verloren. Im .....

Drugs and Medications [0 Results]

None

Clinical Trials [4 Associated Clinical Trials listed on BioPortfolio]

A Study of the Current Medical Practice and Outcomes in the Treatment of Type 2 Diabetes Mellitus in an Office Setting (MK-0431-199)

The purpose of this study is to collect information of the risk profile of patients with type 2 diabetes mellitus, their treatment concerning meeting the guidelines for treatment of diabet...

Opsoclonus Myoclonus Syndrome/Dancing Eye Syndrome (OMS/DES) in Children With and Without Neuroblastoma (NBpos and NBneg)Opsoclonus Myoclonus Syndrome/Dancing Eye Syndrome (OMS/DES) in Children With and Without Neuroblastoma (NBpos and NBneg)

The OMS/DES study is a multinational European Trial for Children with the Opsoclonus Myoclonus Syndrome / Dancing Eye Syndrome. This trial brought on the way by specialists of the EPNS (E...

Ziprasidone for Severe Conduct and Other Disruptive Behavior Disorders

To investigate and compare the efficacy, safety and tolerability of ziprasidone versus placebo in the treatment of conduct disorder (CD), oppositional defiant disorder (ODD) and disruptive...

Effects of Empagliflozin Plus Linagliptin vs Metformin Plus Insulin Glargin on Renal and Vascular Changes in Type 2 Diabetes

Diabetes mellitus is a wide-spread disease accompanied by strongly increased morbidity and mortality due to micro- and macrovascular complications. However, in studies with patients suffer...

Companies [18 Associated Companies listed on BioPortfolio]

BioGenes - Gesellschaft für Biopolymere mbH

BioGenes is a world-wide acting full-service supplier of protein analysis services, customised polyclonal and monoclonal antibodies as well as immunoassays with strong commitment to quality and servic...

ICHTHYOL-GESELLSCHAFT

ICHTHYOL-GESELLSCHAFT, our independent, family-run pharmaceutical company became one of the most important suppliers of therapeutics in dermatology and orthopedics due to active ingredients of high gr...

Gesellschaft für Toxikologie (GT)

NIL

Gesellschaft Deutscher Chemiker

Nil

Fraunhofer-Gesellschaft

The Fraunhofer-Gesellschaft undertakes applied research of direct utility to private and public enterprise and of wide benefit to society. Its services are solicited by customers and contractual partn...

More Information about "BioGenes - Gesellschaft für Biopolymere mbH" on BioPortfolio

We have published hundreds of BioGenes - Gesellschaft für Biopolymere mbH news stories on BioPortfolio along with dozens of BioGenes - Gesellschaft für Biopolymere mbH Clinical Trials and PubMed Articles about BioGenes - Gesellschaft für Biopolymere mbH for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of BioGenes - Gesellschaft für Biopolymere mbH Companies in our database. You can also find out about relevant BioGenes - Gesellschaft für Biopolymere mbH Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...

Diagnostics
A diagnostic test is any kind of medical test performed to aid in the diagnosis or detection of disease. For example: to diagnose diseases to measure the progress or recovery from disease to confirm that a person is free from disease Clin...

Generics Drugs
A generic drug (generic drugs, short: generics) is a drug defined as "a drug product that is comparable to brand/reference listed drug product in dosage form, strength, route of administration, quality and performance characteristics, and intended u...


Corporate Database Quicklinks



Searches Linking to this Company Record